Author | Bob Kronemyer


Early menopause and cardiovascular disease

July 09, 2020


The authors noted that, although recent guidelines embrace using history of menopause before age 40 to refine atherosclerotic cardiovascular disease (ASCVD) risk assessments in middle-aged women, “robust data on cardio-vascular disease risk in this population is lacking.”

Aromatase inhibitors for climacteric symptoms in women with breast cancer

July 08, 2020


New research shows that, in postmenopausal women undergoing hormone therapy for breast cancer, aromatase inhibitors (AIs) lead to a reduction in climacteric symptoms and significantly improved quality of life.

Opioid use in women with endometriosis

July 07, 2020


Nearly two-thirds of women newly diagnosed with endometriosis filled an opioid prescription within the first year, according to a US population-based claims study.

Link between hormone replacement therapy and mammographic density

July 06, 2020


The review concluded that the highest increase in MD is among current users of HRT, particularly those taking continuous estrogen plus progestin (CEP).